JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 106 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $895,000 | +627.6% | 107,198 | +793.3% | 0.00% | – |
| Q1 2021 | $123,000 | +18.3% | 12,000 | -6.4% | 0.00% | – |
| Q3 2020 | $104,000 | -97.4% | 12,824 | -92.8% | 0.00% | -100.0% |
| Q1 2018 | $3,968,000 | +71.9% | 177,500 | -2.0% | 0.00% | +100.0% |
| Q4 2017 | $2,308,000 | -19.6% | 181,066 | -1.7% | 0.00% | 0.0% |
| Q3 2017 | $2,871,000 | +61.2% | 184,243 | +45.2% | 0.00% | 0.0% |
| Q2 2017 | $1,781,000 | -49.8% | 126,908 | -21.4% | 0.00% | -50.0% |
| Q1 2017 | $3,550,000 | – | 161,474 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |